Marae-based study into psychoactive mushroom for treating methamphetamine addiction completes first phase of trials
A brief update via RNZ from Phase I of the clinical trials.
Members of the Tū Wairoa team outside Rangiwaho Marae.
Exciting to have the first participants completing their sessions using Psilocybe mushroom extract at Rangiwaho Marae in Phase I of our Tū Wairua clinical trials.
The focus this year will be on writing up Phase I, optimising cultivation and extraction for consistent dosing, and preparing for Phase II.